Santos Pereira

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

Johan Burisch, Hillel Vardi, Doron Schwartz et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 162 citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +11

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.

William Zabala‐Fernández, Manuel Barreiro‐de Acosta, Ana Echarri et al. · PubMed · 2011 · 48 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +16

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease

Ana Echarri, Virginia Ollero, Manuel Barreiro‐de Acosta et al. · European Journal of Gastroenterology & Hepatology · 2015 · 46 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure

Ana Echarri, Javier Castro, Manuel Barreiro‐de Acosta et al. · Journal of Crohn s and Colitis · 2010 · 40 citations

Medicine, Clinical Sciences, Internal Medicine +17

Ulcerative colitis in northern Portugal and Galicia in Spain

Manuel Barreiro‐de Acosta, Fernando Magro, Daniel Carpio et al. · Inflammatory Bowel Diseases · 2009 · 39 citations

Medicine, Immunology, Pharmacotherapy +15